Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Resistant Ovarian Cancer
NCT00023907Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Jul 2001
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in ovarian cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jul 2001; status: terminated.
02
Drugs
paclitaxel
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00023907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023907.